Table 5.
Sample No | Untreated disks (gp1) | Treated with FLC(gp 2) |
Treated with VOC (gp 3) |
Treated with AMB (gp 4) |
Treated with FLU/AMB (gp 5) |
Treated with VOC/AMB (gp 6) |
|||||
---|---|---|---|---|---|---|---|---|---|---|---|
After 48 h | 1 h | 24 h | 1 h | 24 h | 1 h⁎ | 24 h⁎,a | 1 h⁎ | 24 h⁎⁎,a | 1 h⁎⁎,a | 24 h⁎⁎,a | |
5 | 3.3 ± 0.3 | 3 ± 0.3 | 3 ± 0.6 | 3 ± 0.5 | 2.1 ± 0.3 | 1.2 ± 0.6 | 1 ± 0.5 | 1.3 ± 0.3 | 1.2 ± 0.6 | 1 ± 0.5 | 1 ± 0.9 |
2 | 3.6 ± 0.4 | 3.6 ± 0.5 | 3.5 ± 0.4 | 3.2 ± 0.7 | 3.1 ± 0.4 | 1.6 ± 0.3 | 1.3 ± 0.3 | 1.7 ± 0.4 | 1.4 ± 0.5 | 1.3 ± 0.7 | 1.5 ± 0.3 |
36 | 3.6 ± 0.5 | 3.3 ± 0.4 | 3.3 ± 0.3 | 3 ± 0.3 | 3.1 ± 0.6 | 1.5 ± 0.3 | 1.5 ± 0.4 | 1.6 ± 0.3 | 1.2 ± 0.6 | 1.4 ± 0.7 | 1 ± 0.5 |
4 | 3.8 ± 0.6 | 3.5 ± 0.3 | 3.5 ± 0.4 | 3.3 ± 0.2 | 3 ± 0.4 | 1.7 ± 0.4 | 1.5 ± 0.2 | 1.7 ± 0.2 | 1.3 ± 0.4 | 1.4 ± 0.2 | 1.2 ± 0.3 |
15 | 4.2 ± 0.9 | 4.1 ± 0.7 | 4 ± 0.4 | 3.9 ± 0.5 | 3.5 ± 0.4 | 2.1 ± 0.6 | 2 ± 0.9 | 2 ± 0.4 | 1.8 ± 0.4 | 2 ± 0.4 | 1.7 ± 0.4 |
6 | 5 ± 0.3 | 5 ± 0.3 | 4.6 ± 0.7 | 5 ± 0.2 | 4.5 ± 0.4 | 3.2 ± 0.4 | 3 ± 0.7 | 3.2 ± 0.4 | 3.1 ± 0.4 | 2.8 ± 0.7 | 2.9 ± 0.5 |
27 | 5.4 ± 0.3 | 5.3 ± 0.4 | 5.1 ± 0.4 | 5.1 ± 0.3 | 5 ± 0.6 | 3.4 ± 0.4 | 3.2 ± 0.4 | 3.4 ± 0.6 | 3 ± 0.4 | 3.2 ± 0.7 | 2.8 ± 0.3 |
18 | 6.3 ± 0.4 | 6.1 ± 0.3 | 6 ± 0.7 | 6 ± 0.2 | 5.8 ± 0.2 | 4.5 ± 0.5 | 4.3 ± 0.3 | 4.5 ± 0.4 | 4.3 ± 0.9 | 4.2 ± 0.4 | 4.1 ± 0.9 |
9 | 6.5 ± 0.3 | 6.4 ± 0.4 | 6.4 ± 0.4 | 6 ± 0.3 | 6.2 ± 0.4 | 4.8 ± 0.2 | 4.5 ± 0.4 | 4.2 ± 0.6 | 4 ± 0.2 | 4.2 ± 0.2 | 4 ± 0.7 |
10 | 6.5 ± 0.4 | 6.3 ± 0.2 | 6.2 ± 0.4 | 6 ± 0.6 | 5 ± 0.4 | 4 ± 0.2 | 3.8 ± 0.4 | 4 ± 0.7 | 3.5 ± 0.6 | 4.2 ± 0.4 | 3.8 ± 0.4 |
Statistically significant difference in settling organism’s CFU between untreated and treated biofilms.
Statistically significant difference in settling organism’s CFU between treated biofilms and FLC treated disks.
P ⩽ 0.05 compared with untreated controls.
P ⩽ 0.01 compared with untreated controls.
P ⩽ 0.05 compared with fluconazole treated disks in similar time periods.